Get started
Author

Kimaya M. Bakhle

Observed name: Kimaya Bakhle
ORCID: 0000-0002-7122-0989
Observed ORCID: 0000-0002-7122-0989
OpenAlex ID: A5137641252
The Clock:Cycle complex is a major transcriptional regulator of Drosophila photoreceptors that protects the eye from retinal degeneration and oxidative stress
2022 · Juan Jauregui-Lozano, Hana Hall, et al. · PLoS Genetics · 24
In vivo tissue-specific chromatin profiling in Drosophila melanogaster using GFP-tagged nuclei
2021 · Juan Jauregui-Lozano, Kimaya Bakhle, et al. · Genetics · 16
PDF
Comparative Analysis of microRNAs that Stratify in vitro Mammary stem and Progenitor Activity Reveals Functionality of Human miR-92b-3p
2022 · James L. Miller, Matt Kanke, et al. · Journal of Mammary Gland Biology and Neoplasia · 11
Single institution study of the immune landscape for canine oral melanoma based on transcriptome analysis of the primary tumor
2024 · Isabelle F. Vanhaezebrouck, Kimaya M. Bakhle, et al. · Frontiers in Veterinary Science · 5
Establishing the contribution of active histone methylation marks to the aging transcriptional landscape of Drosophila photoreceptors
2023 · Juan Jauregui-Lozano, Sarah E. McGovern, et al. · Scientific Reports · 5
PDF
CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al. · Cancer Research Communications · 4
Epithelial-mesenchymal plasticity and immunosuppression in canine carcinomas reveals cross-species upregulation of CD109
2026 · Kimaya Bakhle, Sophie Nelissen, et al. · Communications Biology · 3
PDF
Feline mammary carcinomas display evidence of stemness, epithelial-mesenchymal plasticity, and metastasis-associated M2-like macrophage infiltration
2026 · Kimaya M. Bakhle, Sophie R. Nelissen, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
A Comparative Species Framework to Identify Candidate Salivary miRNAs Associated with Breast Cancer Risk
2026 · James L. Miller, Mariza DaCosta, et al. · International Journal of Molecular Sciences
Supplementary Figure S6 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Figure S5 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Figure 2 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Figure S4 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Figure S2 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Table 1 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Figure 4 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Figure 6 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Figure 3 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Figure 1 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Figure S1 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Data from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Figure 5 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Figure S7 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Table 2 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Supplementary Figure S3 from CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy
2026 · Shiney Chandraganti, Caitlyn Sams, et al.
Works count: 32
Citation count: 69
H-index: 5
I10-index: 3
Year
Topic
Type